Empowering Scientific Solutions: How eCommerce is Transforming Laboratory Procurement in Asia Pacific
| | | | | | | | | | | | | |

Empowering Scientific Solutions: How eCommerce is Transforming Laboratory Procurement in Asia Pacific

The Asia-Pacific region is at the forefront of the global business-to-business (B2B) eCommerce revolution, driven by rapid digital transformation and the increasing adoption of digital procurement solutions. The region’s eCommerce market is projected to grow at an impressive compound annual growth rate (CAGR) of 22.74% from 2023 to 2032, reaching USD 121 trillion in revenue.

Trends in Personalized Cancer Diagnostics With Highly Sensitive Digital PCR
| | | |

Trends in Personalized Cancer Diagnostics With Highly Sensitive Digital PCR

Personalized cancer diagnostics tests, known as molecular diagnostics, are genetic tests that can be performed to determine whether patients have an inherited or acquired gene mutation associated with cancer. Cancer is one of the most common forms of disease caused by gene mutations.

Moving Towards Longer-Term Disease Protection With T Cell-Mediated Immunity 
| | | |

Moving Towards Longer-Term Disease Protection With T Cell-Mediated Immunity 

With SARS-CoV2, many people were left wondering about the need for multiple shots, whereas certain vaccines, such as the vaccine for yellow fever, require only one shot in our lifetime. In short, it’s due to a combination of escape variants and dropping levels of antibodies allows for reinfection.

Bispecific Antibodies and Antibody Drug Conjugates: More Complex and Targeted Biologic Therapeutics 
| | |

Bispecific Antibodies and Antibody Drug Conjugates: More Complex and Targeted Biologic Therapeutics 

With the maturation of monoclonal antibodies (mAbs) based cancer immunotherapy drugs that target specific, actionable biomarkers, the biopharmaceutical industry has been developing more complex mAbs, such as bispecific antibodies and antibody drug conjugates. The Business Research Company projects the global monoclonal antibody market will exceed USD 170 billion by 2025 at a 12.9 percent CAGR. And in Asia, several companies are leading the way with these advanced antibody drug pipelines, including Astellas and Daiichi Sankyo in Japan, Adpro in Korea, and Miracogen in China.

Cell and Gene Therapy Development: Four Asian Markets To Look Out For
| | | |

Cell and Gene Therapy Development: Four Asian Markets To Look Out For

Gene therapy involves introducing new genetic material into cells so that abnormal genes causing bad protein-coding functions are altered, replaced or silenced. It is most active in the treatment of cancer, accounting for over 60 percent of clinical trials and over 50 percent of all approved therapies worldwide.